Alexandria Real Estate Equities, Inc.

Insider Reports History

Entity
Company
Location
26 North Euclid Avenue, Pasadena, CA
Signature
ALEXANDRIA REAL ESTATE EQUITIES, INC., By: /s/ Marc E. Binda, Chief Financial Officer and Treasurer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandria Real Estate Equities, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Applied Therapeutics, Inc. 10%+ Owner Common Stock 5.86M $24.8M $4.24 Jun 5, 2024 By subsidiary
Applied Therapeutics Inc. 10%+ Owner Pre-Funded Warrant 1.5M Oct 12, 2023 By subidiary
Applied Therapeutics Inc. 10%+ Owner Pre-Funded Warrant 0 Oct 12, 2023 By subsidiary
GreenLight Biosciences Holdings, PBC Other* Common Stock 0 $0.30 Jul 24, 2023 By Alexandria Venture Investments, LLC

Insider Reports Filed by Alexandria Real Estate Equities, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APLT Applied Therapeutics, Inc. Jun 4, 2024 2 -$1.27M 4 Jun 6, 2024 10%+ Owner
APLT Applied Therapeutics Inc. Nov 29, 2023 2 $0 4 Dec 1, 2023 10%+ Owner
APLT Applied Therapeutics Inc. Nov 2, 2023 2 -$572K 4 Nov 6, 2023 10%+ Owner
APLT Applied Therapeutics Inc. Oct 31, 2023 2 -$781K 4 Nov 2, 2023 10%+ Owner
APLT Applied Therapeutics Inc. Oct 12, 2023 4 $0 4 Oct 16, 2023 10%+ Owner
GRNA GreenLight Biosciences Holdings, PBC Jul 24, 2023 1 $0 4 Jul 26, 2023 Other*
GRNA GreenLight Biosciences Holdings, PBC May 29, 2023 0 $0 3 Jun 8, 2023 Other*
APLT Applied Therapeutics Inc. Jun 27, 2022 6 $5M 4 Jun 29, 2022 10%+ Owner
APLT Applied Therapeutics Inc. Feb 23, 2022 2 $0 4 Feb 25, 2022 10%+ Owner